Development and validation of a new GC-MS method for the detection of tramadol, O-desmethyltramadol, 6-acetylmorphine and morphine in blood, brain, liver and kidney of Wistar rats treated with the combination of heroin and tramadol

Novel N,Cl-doped deep eutectic solvents-based carbon dots as a selective fluorescent probe for determination of morphine in food

In the present study, new N,Cl co-doped carbon dots (N,Cl-CDs) based on deep eutectic solvent (DES) were fabricated by a facile hydrothermal process. This fluorescent probe exhibited a good quantum yield of 14% and was applied for the sensitive and selective quantification of morphine in foods. In addition, the influence of solution pH, interaction time, system temperature, interfering substances and analogues on the determination was also investigated. Under the optimized conditions, the luminescence intensity of carbon dots increased linearly with the addition of morphine in the concentration range of (0.15–280.25) μg mL⁻¹ (R² > 0.9969) and the limit of detection (LOD) of 46.5 ng mL⁻¹. Based on these results, it is suggested that N,Cl-CDs is a promising fluorescent probe for sensitive and selective quantification of morphine in foods.

A schematic illustrating the synthesis and morphine detection of N,Cl-CDs.

A hierarchical 3D camellia-like molybdenum tungsten disulfide architectures for the determination of morphine and tramadol

A practical technique was applied to fabricate MoWS₂ nanocomposite through a one-pot hydrothermal method for use as the electrocatalyst. The characterization of MoWS₂ nanocomposite was investigated by several techniques to identify the size, crystal structure, and elemental composition. MoWS₂ nanocomposite exhibited a unique and well-defined hierarchical structure with neatly and densely piled nanopetals acting as the active sites in the electrocatalytic reactions. A carbon screen-printed electrode (CSPE) modified with interesting MoWS₂ nanopetals (MoWS₂/CSPE) was constructed. Subsequently, the electrochemical oxidation of morphine on fabricated MoWS₂/CSPE was studied. Experimental results confirm that under optimized conditions, the maximum oxidation current of morphine occurs at 275 mV in the case of MoWS₂/CSPE that is around 100 mV more negative than that observed in the case of the unmodified CSPE and about 2.6 times increase was observed for the oxidation peak current. The analytical approach was obtained by differential pulse voltammetry in accordance with the relationship between the oxidation peak current and the morphine concentration. The oxidation peak currents for morphine were found to vary linearly with its concentrations in the range of 4.8 × 10^-8-5.05 × 10^-4 M with the detection limit of 1.44 × 10^-8 M. Two completely separated signals occured at the potentials of 275 mV and 920 mV for oxidation of morphine and tramadol at the surface of MoWS₂/CSPE which are sufficient for determination of morphine in the presence of tramadol. The presence of morphine was also detected in real samples using the introduced approach. Graphical abstract Schematic representation of fabrication of the MoWS₂ nanocomposite through a one-pot hydrothermal method for use as the electrocatalyst. A carbon screen-printed electrode was modified with MoWS₂ nanocomposite. Subsequently, the electrochemical oxidation of morphine on the fabricated electrode was studied.

Evaluation of the Ecstasy influence on tramadol and its main metabolite plasma concentration in rats

BACKGROUND

Tramadol is prone to be abused alone, or in combination with 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy). It was reported that 95% of people with a history of substance abuse in the United States used tramadol in 2004. According to the WHO report in 2016, there was a growing number of tramadol abusers alone or in combination with psychoactive substances such as MDMA in particular in some Middle East countries. Higher concentrations of tramadol in plasma may lead to adverse drug reactions or lethal intoxication. In this study, the effect of MDMA on the pharmacokinetics of tramadol was examined in male rats.

METHODS

The effect of MDMA on Tmax, Cmax, area under the curve, elimination rate, and half-life of tramadol and its metabolites was examined. Two control and two treatment groups were designed. The treatment groups received MDMA 18 h before the administration of tramadol. Jugular vein blood samples were analyzed by high-performance liquid chromatography with fluorescent detector to determine the concentrations of tramadol and its metabolites. Independent-sample t-test was used to define the differences between pharmacokinetic parameters of control and treatment groups.

RESULTS

When tramadol administered intraperitoneally, the absorption rate of this drug was reduced, and a lower Cmax (40%) with longer Tmax (eight-fold) was achieved. MDMA exerted greater inhibitory effects on cytochrome P450 3A4 (CYP3A4) than on cytochrome P450 2D6 (CYP2D6). The M2 metabolite ratio was reduced by half, and because of the inhibition of M2 production, the M1 plasma concentration slightly increased.

CONCLUSIONS

According to the obtained data, MDMA treatment affected the absorption, distribution and metabolism phases of tramadol. This treatment increased the concentration of tramadol if administered intravenously and can latent the absorption of tramadol in oral route. However, MDMA was introduced as CYP2D6 inhibitor; in this study, MDMA inhibited CYP3A4 isoenzymes as well. This finding is important for the compounds that are metabolized through CYP3A4. It can be proposed that in abusers of MDMA who only receive tramadol for medical or nonmedical purposes in short intervals, the dangers of the intravenous administration of tramadol should be considered, and if tramadol is administered orally, the desired effect may not be achieved at the routine dose.

Recent configurations and progressive uses of magnetic molecularly imprinted polymers for drug analysis

Since the introduction of the molecularly imprinting technology (MIT) in the 1970s, it becomes an emerging technology with the potential for wide-ranging applications in drug determination. With the rise of green chemistry, many researchers began to focus on the application and development of green materials which led to the breakthrough of molecularly imprinted polymers (MIPs) in the green chemistry. Because of the low concentration levels in the human matrices, almost adequate analytical methods should be used for quantification of drugs at the trace levels. In recent years there have been reported benefits of combining MIPs with additional features, e.g. magnetic properties, through the build-up of this type of material on magnetite particles. Magnetic molecularly imprinted polymer (MMIP) is a new material which is composed of magnetic material and non-magnetic polymer material and shares the characteristics of high adsorption capacity to template molecule, special selective recognition ability, and the magnetic adsorption property. These materials have been widely used in the different fields such as chemical, biological and medical science. This review describes the novel configurations and progressive applications of magnetic molecularly imprinted polymers to the drug analysis. Also, the advantages and drawbacks of each methodology, as well as the future expected trends, are evaluated.

Development of Quantum Dots-Labeled Antibody Fluorescence Immunoassays for the Detection of Morphine

Quantum dots (QDs)-labeled antibody fluorescence immunoassays (FLISA) for the detection of morphine were developed. Quantum dots (CdSe/ZnS), which contained carboxyl, were used to label antimorphine antibody by 1-ethyl-3-(3-dimethylaminoprophyl) carbodiimide hydrochloride/N-hydroxysulfosuccinimide, which were used as coupling reagents. The CdSe/ZnS QDs labeled antimorphine antibody (QDs labeled Ab) was characterized by fluorescence spectrum and gel electrophoresis. Plate-based FLISA and nitrocellulose membrane-based flow-through FLISA were developed and applied to quantitative and qualitative detection of morphine. Under the optimal conditions for plate-based FLISA, the linear range spanned from 3.2 × 10^-4 to 1 mg/L (R² = 0.9905), and the detection limit was 2.7 × 10^-4 mg/L. The visual detection limit for morphine by membrane-based flow-through FLISA was 0.01 mg/L. These results demonstrated that the developed fluorescence immunoassays could be applied as highly sensitive and convenient tools for rapid detection of morphine, which make it ideally suited for on-site screening of poppy shell added illegally in hot pot soup base.

Ultrasonic-assisted magnetic solid phase extraction of morphine in urine samples by new imprinted polymer-supported on MWCNT-Fe3O4-NPs: Central composite design optimization

Multiwalled carbon nanotubes (MWCNTs) were magnetized with Fe3O4 nanoparticles (MWCNTs-Fe3O4-NPs) and subsequently coated by vinyl end groups (Vinyltrimethoxysilane). MWCNT-Fe3O4-NPs were used as support for a new morphine (MO) molecularly imprinted polymer (MWCNT-Fe3O4-NPs@MO-MIP) by surface imprinting polymerization method. The MWCNT-Fe3O4-NPs@MO-MIP was characterized by FTIR, VSM and SEM techniques and successfully used for determination of MO. Ultrasonic-assisted magnetic solid phase extraction followed by UV-vis spectrophotometer (UAMSPE-UV-vis) was investigated for MWCNT-Fe3O4-NPs@MO-MIP and compared with non-imprinted polymer (NIP) using batch method. Central composite design under response surface methodology was used for the evaluation of the effect of variables, individually, as well as their possible interaction effects on the adsorption process. The variables such as sonication time, MWCNT-Fe3O4-NPs@MO-MIP mass, initial concentration of MO and pH were investigated in this study. At optimum experimental conditions, UAMSPE-UV-vis method was exhibited a linear range of 0.8-8.7mgL(-1) of the MO concentration with a detection limit of 0.18mgL(-1). The relative standard deviation for the analyte was found to be lower than 2.32%. The MWCNT-Fe3O4-NPs@MO-MIP adsorption capacity was found to be 37.01mgg(-1). The enrichment and preconcentration factors were found to be 107.01 and 98.21, respectively. The developed method was finally applied successfully to the determination of MO in urine and wastewater samples with the recoveries ranged from 96.40 to 105.6%.

Endogenous opiates and behavior: 2013

This paper is the thirty-sixth consecutive installment of the annual review of research concerning the endogenous opioid system. It summarizes papers published during 2013 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior, and the roles of these opioid peptides and receptors in pain and analgesia; stress and social status; tolerance and dependence; learning and memory; eating and drinking; alcohol and drugs of abuse; sexual activity and hormones, pregnancy, development and endocrinology; mental illness and mood; seizures and neurologic disorders; electrical-related activity and neurophysiology; general activity and locomotion; gastrointestinal, renal and hepatic functions; cardiovascular responses; respiration and thermoregulation; and immunological responses.